about
Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusionA microRNA code for prostate cancer metastasis.Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesisApoptotic role of Fas/Fas ligand system in the regulation of erythropoiesisCancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor.Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor.Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis.Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancerTherapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancerCHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion.Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera.Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency.Colorectal cancer stem cells: from the crypt to the clinic.Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway.The secret life of quiescent cancer stem cellsTGFβ-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies.Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells.Therapeutic targeting of cancer stem cells.The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesisReprogramming: so simple, so complex.Apoptosis within bovine follicular cells and its effect on oocyte development during in vitro maturation.Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins.Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.Activity of the BH3 mimetic ABT-737 on polycythemia vera erythroid precursor cells.Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.Chemotherapy resistance of glioblastoma stem cells.Not so lonely at the top for cancer stem cells.Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1Erythropoietin Activates Cell Survival Pathways in Breast Cancer Stem-like Cells to Protect Them from ChemotherapyEpCAM-Expressing Circulating Tumor Cells in Colorectal Cancer
P50
Q24336627-78C7E154-DB6E-4A4B-A1EA-BBC065ACDCC1Q26825749-21FCA6BC-8AFB-460F-AD93-6D37EA856107Q27310006-4E124E79-D1E7-48C6-92C3-AD32EF0B8ED3Q28262934-4419EF18-CBB0-41C5-BC59-29055978C304Q28295394-8E678E77-C74F-4EA2-8A0E-917FF422551CQ30729579-15F1364C-C747-4AC7-A57D-7D277C31BCE7Q33375296-C3121E88-7697-468D-9B5B-B0CF4BC0C5CDQ33396868-477FB6A5-872A-46DB-9849-34F3AB099D20Q34438239-94CE838E-5931-4262-B566-0895FBFCB2D5Q34486401-06BA95F9-054E-423D-B7CB-1C6186BEB6CAQ35876285-8E367ADE-821D-4AA2-B806-658CF07171D0Q36040592-703529CF-5CEE-4A17-8E27-81149E97C75BQ36340540-5AE5D356-9FC3-421A-898F-646D64188F5BQ36544778-AFACD53F-13F5-4C44-BC0B-DAF95E3C10B8Q36715955-F736AB92-1943-4DD3-A714-D0AE8982650FQ37166443-635ED774-7232-45D3-B36D-B0A639E16AB6Q37260904-DB17390C-D79C-4392-9A03-5A21662D98CEQ38283848-5E623735-570B-4B86-AED7-447AE5D05468Q39321299-042BDD04-E942-4015-ADFA-2F09CE8B857FQ39344938-EC1D6D8A-AB8D-4D42-9117-5F380A6249EDQ40165719-11CBEC83-3904-4AD3-83D3-2B66A528A72BQ40564344-6EA6FC76-F341-4A3D-B776-B5A943E66CEEQ41005067-B62DF51A-5120-4EFE-940C-8996F21A48D8Q41896472-ADDB9B55-3F84-4896-AA2D-0C3D24213940Q42031459-D74E3392-98A1-40FC-A31A-C210B3A1FB44Q42164081-9060FC6B-76E7-4679-BC43-57A3D8961C49Q42175003-B18A1A9F-EA89-4749-8999-16A0795FC77DQ42228905-017821FC-36AC-413A-A86D-AB6A3B7341B3Q43218298-9C3CB943-27C7-454A-8B32-F93B2EE40CF4Q44277632-2DEB78D6-30DF-47B8-835B-524DD42314EAQ44362013-59C7045C-2018-4BBA-AA1E-73F014648C5CQ44516514-537AA8C3-2D96-4736-9657-F5F41C3292E9Q46211823-9171669F-2D1E-411B-A0C1-D12692978946Q46872510-EBD11B36-3235-4EF6-9471-D59DFB5F8683Q46926270-61AB3BF3-6BA1-4868-A09F-3867037ABF0BQ47575574-667FD108-AD75-4B4C-BC0D-A1B831E59604Q49196561-D365C959-CD22-4A0E-B2FB-CEA3B96F82B7Q59341249-73F52866-F33A-45FD-AF1A-8974BE7A96A7Q60168778-3C35829C-C74B-4687-8454-C52096BA8206Q61046236-5977EB19-B91B-491E-AB62-64533365401B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ann Zeuner
@ast
Ann Zeuner
@en
Ann Zeuner
@es
Ann Zeuner
@nl
type
label
Ann Zeuner
@ast
Ann Zeuner
@en
Ann Zeuner
@es
Ann Zeuner
@nl
prefLabel
Ann Zeuner
@ast
Ann Zeuner
@en
Ann Zeuner
@es
Ann Zeuner
@nl
P1053
A-8529-2010
P106
P21
P31
P3829
P496
0000-0002-8295-3715